Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
The Lancet Respiratory Medicine (2021) - Comments
doi: 10.1016/s2213-2600(21)00310-6  issn: 2213-2600  pubmed: 34329624  issn: 2213-2619 

Christopher C Butler, Ly-Mee Yu, Jienchi Dorward, Oghenekome Gbinigie, Gail Hayward, Benjamin R Saville, Oliver Van Hecke, Nicholas Berry, Michelle A Detry, Christina Saunders, Mark Fitzgerald, Victoria Harris, Ratko Djukanovic, Stephan Gadola, John Kirkpatrick, Simon De Lusignan, Emma Ogburn, Philip H Evans, Nicholas P B Thomas, Mahendra G Patel